Why the study?
This study aimed to examine the clinical benefits of targeted ablation of all premature ventricular complex morphologies versus predominant PVC only in patients with multiple morphologies.
Does targeted ablation of all PVC morphologies improve PVC burden and LVEF in patients with reduced LVEF and multiple PVC morphologies compared to ablation of the dominant PVC only?
Does targeted ablation of all PVC morphologies improve PVC burden and LVEF in patients with reduced LVEF and multiple PVC morphologies compared to ablation of the dominant PVC only?
In patients with reduced LVEF and multiple PVC morphologies, ablating all morphologies rather than just the dominant one significantly reduces long-term PVC burden and improves LVEF.
May support comprehensive PVC ablation to reduce recurrences in reduced LVEF; hypothesis-generating and needs randomized confirmation.
AIMS: This study aimed to examine the clinical benefits of targeted ablation of all Premature ventricular complex (PVC) morphologies vs. predominant PVC only. METHODS AND RESULTS: A total of 171 consecutive patients with reduced left ventricular ejection fraction (LVEF) and ≥2 PVC morphology with high burden (>10%/day) undergoing their first ablation procedure were included in the analysis. At the initial procedure, prevalent PVC alone was ablated in the majority. However, at the redo, all PVC morphologies were targeted for ablation. : At the first procedure, 152 (89%) patients received ablation of the dominant PVC only. In the remaining 19 (11%) patients, all PVC morphologies were ablated. At two years, high PVC burden was detected in 89 (52%) patients. Repeat procedure was performed in 78 of 89, where all PVC morphologies were ablated. At 5 years after the repeat procedure, 71 (91%) had PVC burden of <5% [3.8 ± 1.1% vs. 15.4 ± 4.3% in successful vs. failed subjects (P < 0.001)]. In patients with low PVC burden after the initial procedure, LVEF improved from 37.5% to 41.6% [mean difference (MD): 3.39 ± 2.9%, P < 0.001], whereas a reduction in LVEF from 39.8% to 34.5% (MD: 6.45 ± 4.7%, P < 0.001) was recorded in patients with high PVC burden. One year after the repeat procedure, LVEF improved from 36.2% to 41.7% (MD: 5.5 ± 4.3%, P < 0.001) in patients with successful ablation. CONCLUSION: In this observational series, ablation of all PVC morphologies was associated with significantly lower PVC burden and improvement of LVEF at long-term follow-up, compared with ablation of the dominant morphology only.
No takes yet. Share an insight, caveat, or question.
Mohanty et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: